Orange Book product · Brand (NDA)
VERZENIO
ABEMACICLIB
At a glance
Sep 28, 2017
Approved
Brand (NDA)
Application
Not listed
TE code
4
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 28, 2017
8 yr 10 mo ago
Today
Patent 7855211 expires
Listed drug substance patent expiration.
Sep 28, 2031
in 5 yr 4 mo
Patent 7855211 expires
Listed drug substance patent expiration.
Sep 28, 2031
in 5 yr 4 mo
Patent 7855211 expires
Listed drug substance patent expiration.
Sep 28, 2031
in 5 yr 4 mo
Patent 7855211 expires
Listed drug substance patent expiration.
Sep 28, 2031
in 5 yr 4 mo
Pharmaceutical detail
Active ingredient
ABEMACICLIB
Strength
50MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 208716
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7855211 | Sep 28, 2031 | in 5 yr 4 mo | SubstanceProductU-2135 |
| 7855211 | Sep 28, 2031 | in 5 yr 4 mo | SubstanceProductU-3546 |
| 7855211 | Sep 28, 2031 | in 5 yr 4 mo | SubstanceProductU-3265 |
| 7855211 | Sep 28, 2031 | in 5 yr 4 mo | SubstanceProductU-3242 |
